Johnson & Johnson (JNJ) News

Johnson & Johnson (JNJ): $178.88

0.14 (+0.08%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter JNJ News Items

JNJ News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

JNJ News Highlights

  • For JNJ, its 30 day story count is now at 30.
  • Over the past 24 days, the trend for JNJ's stories per day has been choppy and unclear. It has oscillated between 1 and 5.
  • The most mentioned tickers in articles about JNJ are SAFE, ABBV and APP.

Latest JNJ News From Around the Web

Below are the latest news stories about JOHNSON & JOHNSON that investors may wish to consider to help them evaluate JNJ as an investment opportunity.

Why Is Horizon Therapeutics (HZNP) Stock Up 30% Today?

Horizon Therapeutics (HZNP) stock is rising higher on Wednesday following reports that the company is considering a buyout.

William White on InvestorPlace | November 30, 2022

Horizon Therapeutics in Separate Sale Talks With Amgen, Sanofi, J&J

(Bloomberg) -- Horizon Therapeutics Plc soared in post-market US trading after the developer of medicines for rare autoimmune and inflammatory diseases said it’s in talks with a trio of potential suitors about a possible sale of the company.Most Read from BloombergScientists Revive 48,500-Year-Old ‘Zombie Virus’ Buried in IceBanks Stuck With $42 Billion Debt Seize Chance to Offload ItThese Are the Best and Worst Cities for Expats to Live and Work InApple to Lose 6 Million iPhone Pros From Tumult

Yahoo | November 29, 2022

Horizon Therapeutics Fields Takeover Interest From Pharma Giants

The drugmaker recently had a market value almost $18 billion as big pharmaceutical companies rely on acquisitions to expand sales.

Yahoo | November 29, 2022

‘A paid hack’: Nouriel Roubini just tore into Kevin O'Leary for his ties to bankrupt FTX, hopes CNBC will 'get rid of him' — but Mr. Wonderful still loves these low-risk stocks for income

Cash flow remains king.

Yahoo | November 29, 2022

10 Best 5% Dividend Stocks To Buy According To Hedge Funds

In this article, we will discuss the best dividend stocks according to hedge funds with over 5% yield. You can skip our detailed analysis of dividend stocks and their performance over the years, and go directly to read 5 Best 5% Dividend Stocks To Buy According To Hedge Funds. The current stock market situation has […]

Yahoo | November 28, 2022

Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It

Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Yahoo | November 28, 2022

Retirement Stock Portfolio: 11 Safe Dividend Stocks to Consider

In this article, we discuss the 11 safe dividend stocks for a retirement stock portfolio. If you want to read about some more dividend stocks, go directly to Retirement Stock Portfolio: 5 Safe Dividend Stocks to Consider. Across the world, investors have been scrambling to find ways to strengthen their portfolios and reduce risk as […]

Yahoo | November 28, 2022

15 Best Dividend Stocks of All Time

In this article, we discuss the best dividend stocks of all time. You can skip our detailed analysis of dividend stocks and their returns over the years, and go directly to read 5 Best Dividend Stocks of All Time. This year has been challenging for investors due to continuous interest rate hikes and an all-time […]

Yahoo | November 27, 2022

15 Biggest Holding Companies in the World

In this piece, we will take a look at the 15 biggest holding companies in the world. For more companies, head on over to 5 Biggest Holding Companies in the World. A holding company is quite common in the business world, especially when it comes to large firms operating in lucrative industries such as finance. […]

Yahoo | November 27, 2022

Up 32% in 2022, Is Eli Lilly Stock Still a Buy?

The consumer price index increased 7.7% year over year in October, a solid signal that the inflation rate is now trending in the right direction. The pharma stock Eli Lilly (NYSE: LLY) is chief among these stocks. Let's take a look under the hood at Eli Lilly's fundamentals and valuation to decide.

Yahoo | November 27, 2022


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6164 seconds.